Exploring Price Transparency Actions In Europe
Drug Pricing, An Issue That Will Not Go Away
Drug pricing is an issue that is not going to go away. For many the problem relates to prices being too high, for others it is simply that the real prices paid for products is not clear, nor is it transparent how those prices come about.
You may also be interested in...
The signs suggest that Nicola Magrini, the new director general of the Italian medicines regulator, AIFA, will follow in the footsteps of his predecessor in fighting for transparency in drug pricing.
In Belgium, there are increasing tensions between drug price transparency and getting the best deal for the Belgian government.
The new appointments to the top jobs at NICE may bring continuity at a challenging time for the institute, but perhaps not the real change that some in the industry say is needed.